export const jna = {
  intro: "Hello let's start",
  questionAndAnswers: [
    {
      question: "Please describe this image?",
      sample_answer: "This is a saggital section of a CT scan of the sinuses showing opacification of the maxillary sinus with an expansile soft tissue mass of the pterogyopalatine fossa causing bowing of the posterior wall of the maxillary sinus.",
    },
    {
      question: "What would be your differential diagnosis for a lesion filling the right maxillary sinus?",
      sample_answer: "My differential diagnosis for a lesion filling the right maxillary sinus includes benign conditions like nasal polyposis, antrochoanal polyp, inverted papilloma, and pyogenic granuloma. For malignant possibilities, I would consider rhabdomyosarcoma, nasopharyngeal carcinoma, and lymphoma. Given the previous CT scan, juvenile nasopharyngeal angiofibroma (JNA) is highly likely, although it typically arises from the lateral nasal wall near the sphenopalatine foramen and may extend into the maxillary sinus.",
    },
    {
      question: "The patient is a 15-year-old male presenting with epistaxis. What would you inquire about during your history taking for this patient?",
      sample_answer: "In assessing a 15-year-old male presenting with epistaxis, my history taking would be thorough and multifaceted to uncover any underlying conditions, focusing on: Symptomatology: Duration and frequency of epistaxis: To assess chronicity and potential causes. Laterality of epistaxis: JNA typically presents with unilateral symptoms but can become bilateral as it grows. Presence of nasal obstruction or rhinorrhea: Common in JNA and other nasal masses. Headaches or facial pain: May indicate tumor extension. Changes in vision or eye symptoms like proptosis or diplopia: Suggestive of orbital involvement. Medical History: History of allergies or sinus infections: To rule out other common causes of nasal symptoms. Family History: Any similar cases in the family or related conditions like familial adenomatous polyposis (FAP), given the increased risk of JNA in patients with FAP.",
    },
    {
      question: "What would you look for during your examination of this patient?",
      sample_answer: "During the physical examination of a 15-year-old male with epistaxis and potential JNA, I would focus on: Nasal Examination: Visual inspection for external deformity or swelling: Indicative of mass effect. Anterior rhinoscopy and fiberoptic nasoendoscopy (FNE) to assess for masses: A well-circumscribed, lobulated, purple/red mass in the nasal cavity or nasopharynx is characteristic of JNA. Examination of nasal septum for deviation: Often seen in response to mass effect. Head and Neck Examination: Palpation for facial swelling: Especially if the pterygopalatine fossa is involved. Assessment of ocular movements and the presence of proptosis: To evaluate orbital involvement. Inspection for any signs of cranial nerve deficits: Indicative of intracranial extension.",
    },
    {
      question: "What investigations would you undertake for this patient?",
      sample_answer: "I would pursue a series of diagnostic investigations focused on imaging to elucidate the nature and extent of the lesion: Imaging Studies: CT Scan of the Paranasal Sinuses with Contrast: To assess bone involvement, including characteristic findings like anterior bowing of the posterior maxillary wall (Holman-Miller sign) and widening of the sphenopalatine foramen. MRI with Contrast (T1 fat-saturated post-gadolinium and T2 images): To evaluate soft tissue extension, particularly intracranial, infratemporal fossa, and orbital involvement. Expected to show a 'salt and pepper' appearance due to flow voids, indicative of the vascular nature of JNA. Digital Subtraction Angiography: Primarily for preoperative planning in confirmed cases, to delineate the vascular supply for potential embolization. Laboratory studies like Full blood count and clotting studies will aid with understanding the severity of the epistaxis, treatment of any anaemia and surgical planning.",
    },
    {
      question: "Describe the Fisch staging system for JNA.",
      sample_answer: "The Fisch staging system categorizes JNA based on tumor location and extent of bony destruction: Stage I: Tumor limited to the nasopharynx with negligible or no bony destruction. Stage II: Extension into the pterygopalatine fossa or paranasal sinuses with minimal bony destruction. Stage III: Tumor invading the infratemporal fossa or orbit. Divided into IIIa (without intracranial involvement) and IIIb (intracranial extradural involvement). Stage IV: Intracranial intradural involvement. IVa lacks cavernous sinus, pituitary fossa, or optic chiasm infiltration, while IVb involves these structures.",
    },
    {
      question: "What is the difference between the Fisch and the UPMC staging system?",
      sample_answer: "The primary difference lies in their focus: The Fisch system is based on tumor location and bony destruction, while the UPMC system, developed for endoscopic approaches, emphasizes tumor vascularity and skull base involvement route. The UPMC system also considers tumor size and extent of sinus disease less crucial than in the Fisch system.",
    },
    {
      question: "What is the pathophysiology of JNA?",
      sample_answer: "JNA is a benign yet locally aggressive vascular tumor that occurs exclusively in adolescent males, suggesting a hormonal influence on its development. The tumor originates from the lateral nasal wall near the sphenopalatine foramen. Its pathophysiology involves: Lack of smooth muscle and elastic fibers in the blood vessel walls, leading to a propensity for bleeding as the vessels cannot undergo vasospasm. The tumor is thought to have an etiological basis linked to hormonal changes around puberty, with increased expression of hormonal receptors and vascular endothelial growth factor (VEGF). Theories also suggest that JNA may arise due to a desmoplastic response or from embryonic fibrocartilage residues in the nasopharyngeal periosteum. These factors contribute to JNA's characteristic growth patterns, including its slow expansion and tendency to invade adjacent structures without metastasizing.",
    },
    {
      question: "What are the histological features of JNA?",
      sample_answer: "Histologically, JNA is characterized by: A vascular tumor with an irregular vascular component, featuring large, 'staghorn-shaped' vessels that lack smooth muscle in their walls, making them prone to bleeding. High collagen content within the stroma, contributing to its fibrous nature. The absence of a capsule, which partially explains its aggressive local behavior. Positive staining for VEGF and vimentin, with the tumor expressing androgen and estrogen receptors in some cases.",
    },
    {
      question: "What is the blood supply of the JNA?",
      sample_answer: "The primary blood supply of JNA comes from the internal maxillary artery, a branch of the external carotid artery. However, as the tumor grows, it can also receive blood from: Direct branches from the internal carotid artery (ICA). The ascending pharyngeal artery. Potentially bilateral sources, depending on the extent of tumor spread. This rich vascular network is a key consideration for preoperative embolization and surgical planning, given the tumor's propensity for significant bleeding.",
    },
    {
      question: "What are your options for managing this child with JNA?",
      sample_answer: "For managing a child diagnosed with JNA, the treatment approach is primarily surgical, but the management strategy can be comprehensive, including: Surgical Removal: The mainstay of treatment, aiming for complete resection of the tumor. The choice between endoscopic and open surgical approaches depends on the tumor's size, location, and extent. Preoperative Embolization: Performed 24â€“72 hours before surgery to reduce the tumor's vascularity and minimize intraoperative bleeding. This improves surgical outcomes by enhancing visualization and reducing blood loss. Medical Management: While surgery is the primary treatment, adjunct medical therapy can include hormonal therapy with testosterone receptor blockers (e.g., flutamide) or estrogen to potentially reduce vascularity and size of the tumor, though this is less common. Radiotherapy: Reserved for residual or recurrent tumors that are not amenable to surgery, or for tumors extending into areas where surgery would cause unacceptable morbidity. However, due to considerable side effects, especially in adolescents, its use is limited.",
    },
    {
      question: "What are the risks and benefits of preoperative embolization?",
      sample_answer: "Preoperative embolization of JNA is aimed at reducing intraoperative blood loss and improving surgical visualization by decreasing the tumor's vascularity. However, it carries its own set of risks and benefits: Benefits: Significantly reduces intraoperative blood loss, potentially decreasing the need for transfusions. Enhances the surgical field's visibility by minimizing bleeding, allowing for a more precise and safer tumor resection. Risks: Embolic complications, including stroke and vision loss, though rare. May obscure tumor boundaries by reducing vascularity, complicating the surgical approach. Potential to render the tumor more radioresistant due to induced hypoxia, affecting adjuvant therapy options.",
    },
    {
      question: "Discuss the options for surgical management.",
      sample_answer: "Surgical management of JNA involves various approaches based on the tumor's stage and anatomical extent: Endoscopic Surgery: Preferred for early-stage tumors (Stage I and II) where complete resection can be achieved through a minimally invasive approach. Offers the advantage of reduced morbidity and recovery time. Open Surgical Approaches: Necessary for advanced tumors (Stage III and IV) with extensive involvement of the pterygopalatine fossa, infratemporal fossa, or intracranial extension. Techniques include lateral rhinotomy, Caldwell-Luc procedure, midfacial degloving, and craniofacial resection. Combined Approaches: For tumors with complex extension patterns, a combination of endoscopic and open approaches may be employed to ensure complete removal while minimizing functional and cosmetic impact.",
    },
    {
      question: "What conditions are associated with JNA?",
      sample_answer: "JNA has been specifically associated with familial adenomatous polyposis (FAP), where patients with FAP have a significantly increased risk, up to 25 times greater, of developing JNA. This association suggests a potential genetic or molecular link between these two conditions. The relationship underscores the importance of a thorough patient history and possibly genetic counselling for patients diagnosed with JNA, particularly if there is a family history of FAP or other related genetic conditions. Awareness of this association is crucial for comprehensive patient care, including surveillance for other manifestations of FAP in patients diagnosed with JNA.",
    },
  ],
};
